Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
Article in Oncotarget (April 2016)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Biweekly dose‐dense gemcitabine–oxaliplatin and dexamethasone for relapsed/refractory aggressive non‐Hodgkin lymphoma: A multicenter, single‐arm, phase II trial
Article in Asia-Pacific Journal of Clinical Oncology (March 2016)
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study
Article in Leukemia & Lymphoma (August 2014)